Background: Fourteen clinical trials have not shown a consistent benefit of combination
therapy with levothyroxine (LT4) and liothyronine (LT3). Despite the publication of these …

Hypothyroidism is a common endocrinopathy, and levothyroxine is frequently prescribed.
Despite the basic tenets of initiating and adjusting levothyroxine being agreed on, there are …

Numerous randomized controlled trials have been conducted to determine efficacy of
exercise on cancer-related fatigue. However, many trials lacked sufficient power to …

Background The primary objective of this systematic review was to update our previous
review on randomized controlled trials (RCTs) of exercise in cancers other than breast or …

A significant minority of patients with hypothyroidism report persistent symptoms despite
achieving normal thyroid biochemistry after levothyroxine (L‐T4) replacement. Four principal …

Background: Hypothyroid patients often report dissatisfaction and poor quality of life. This
survey explored the impact of hypothyroidism on patient satisfaction, everyday living …

The rationale behind thyroid hormone suppression therapy is the knowledge that thyroid-
stimulating hormone (TSH), secreted by the pituitary, affects growth and proliferation of …

Background: Thyrotropin (TSH)-suppressive doses of levothyroxine (LT4) have adverse
effects on bone and cardiac function, but it is unclear whether metabolic function is also …

Objectives Randomised controlled trials (RCTs) can evaluate how well a particular exercise
programme reduces cancer treatment-related side effects. Adequate design and reporting of …

Simple Summary This narrative review provides a comprehensive overview of the
prehabilitation and rehabilitation strategies to manage thyroid cancer survivors, focusing on …